Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00201890 | Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY" | completed | Phase 3 | 103 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT00917748 | Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) | completed | Phase 3 | 84 | SanofiINDUSTRY | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00605267 | Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | completed | Phase 3 | 197 | AstraZenecaINDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01662128 | Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer | unknown | Phase 2 / Phase 3 | 600 | Tianjin Medical UniversityOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT01648608 | Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer | unknown | Phase 2 / Phase 3 | 600 | Tianjin Medical UniversityOTHER | 1 | Aug 3, 2012 | clinicaltrials |
| NCT00256698 | Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy(FACT) | completed | Phase 3 | 514 | AstraZenecaINDUSTRY | 12 | Aug 1, 2012 | clinicaltrials |
| NCT01654367 | Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer(esozao) | unknown | Phase 2 / Phase 3 | 300 | Tianjin Medical UniversityOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00008411 | Docetaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 3 | 90 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00343616 | Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 | completed | Phase 3 | 135 | ETOP IBCSG Partners FoundationNETWORK | 6 | Jul 27, 2012 | clinicaltrials |
| NCT00369850 | Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | completed | Phase 3 | 458 | ETOP IBCSG Partners FoundationNETWORK | 8 | Jul 27, 2012 | clinicaltrials |
| NCT00899288 | Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 | terminated | Phase 3 | 60 | ETOP IBCSG Partners FoundationNETWORK | 0 | Jul 27, 2012 | clinicaltrials |
| NCT01647672 | Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer | unknown | Phase 2 / Phase 3 | 60 | Tianjin Medical UniversityOTHER | 1 | Jul 25, 2012 | clinicaltrials |
| NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | completed | Phase 3 | 74 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00010153 | ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer | terminated | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00028704 | Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy | terminated | Phase 3 | 26 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 18, 2012 | clinicaltrials |
| NCT00049660 | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 / Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT01501669 | Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer(PROCEED) | unknown | Phase 3 | 222 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00002777 | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 342 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Jul 2, 2012 | clinicaltrials |
| NCT00006459 | Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00849030 | ATAC - Arimidex, Tamoxifen Alone or in Combination | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | Jun 6, 2012 | clinicaltrials |
| NCT00403182 | Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer | withdrawn | Phase 3 | 0 | Technical University of MunichOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT01587248 | Use of Harmonic in Breast Surgery(HMRM) | completed | Phase 3 | 152 | Aga Khan UniversityOTHER | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00171314 | The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer | completed | Phase 3 | 527 | Novartis PharmaceuticalsINDUSTRY | 9 | Apr 11, 2012 | clinicaltrials |
| NCT00670878 | Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer | completed | Phase 3 | 799 | Ludwig-Maximilians - University of MunichOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | completed | Phase 3 | 273 | M.D. Anderson Cancer CenterOTHER | 4 | Feb 14, 2012 | clinicaltrials |
| NCT01508546 | Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer | completed | Phase 3 | 565 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00002646 | Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | completed | Phase 3 | 1,500 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jan 5, 2012 | clinicaltrials |
| NCT00245050 | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer | completed | Phase 3 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00309556 | Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer | completed | Phase 3 | 536 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
| NCT01378533 | The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC | unknown | Phase 3 | 100 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 28, 2011 | clinicaltrials |
| NCT00944424 | Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca(GORG-002) | unknown | Phase 3 | 260 | King Faisal Specialist Hospital & Research CenterOTHER | 3 | Dec 13, 2011 | clinicaltrials |
| NCT01479036 | Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer(CBCRT01) | unknown | Phase 3 | 800 | Xijing HospitalOTHER | 1 | Nov 24, 2011 | clinicaltrials |
| NCT01452672 | Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer | unknown | Phase 3 | 600 | International Atomic Energy AgencyOTHER_GOV | 8 | Oct 17, 2011 | clinicaltrials |
| NCT00236899 | Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC | completed | Phase 3 | 241 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00712140 | Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | unknown | Phase 3 | 4,000 | Warwick Medical SchoolOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00896155 | Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients(CONSET) | unknown | Phase 3 | 260 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 30, 2011 | clinicaltrials |
| NCT00376740 | Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole | completed | Phase 3 | 90 | Soroka University Medical CenterOTHER | 1 | Aug 23, 2011 | clinicaltrials |
| NCT01415336 | AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer | unknown | Phase 2 / Phase 3 | 300 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT01412788 | Safety and Aesthetic Outcomes of Breast Conserving Surgery With Peri-areolar Incision Approach | unknown | Phase 3 | 100 | Peking Union Medical College HospitalOTHER | 1 | Aug 9, 2011 | clinicaltrials |
| NCT00645138 | Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery | completed | Phase 3 | 40 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | completed | Phase 3 | 680 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | completed | Phase 3 | 1,300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00186212 | Alternative Support for Rural and Isolated Women in an HMO | completed | Phase 3 | 150 | Stanford UniversityOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00525096 | Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer | completed | Phase 3 | 157 | ARCAGY/ GINECO GROUPOTHER | 0 | Jun 30, 2011 | clinicaltrials |
| NCT00352378 | Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer | completed | Phase 3 | 209 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00294385 | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | completed | Phase 3 | 430 | Central European Cooperative Oncology GroupOTHER | 7 | Jun 23, 2011 | clinicaltrials |
| NCT00942396 | Study to Compare the Diagnostic Accuracy of Nuance Full-Field Digital Mammography to Screen-Film Mammography | withdrawn | Phase 3 | 250 | Planmed OyINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Oct 10, 2012source: clinicaltrials